Table 2.

Characteristics of studied groups

				p
	CT2DM	LOADDM	N	N vs CT2DM	N vs LOADDM
n	48	18	42	NS	NS
age (years)	65.6 ± 7.1	67.4 ± 10.8	63.0 ± 11.2	NS	NS
age at diagnosis (years)	54.9 ± 8.4	54.7 ± 10.0	-	-	-
weight (kg)	73.2 ± 13.7	73.4 ± 15.3	61.4 ± 13.4	<0.01	<0.05
BMI (kg/m2)	28.7 ± 4.2	28.5 ± 4.3	25.3 ± 3.7	<0.01	<0.05
waist (cm)	98.7 ± 10.7	99.4 ± 13.0	86.3 ± 9.9	<0.01	<0.01
Systolic BP (mmHg)	125.3 ± 16.0	118.0 ± 13.6	130.1 ± 17.3	NS	<0.05
Diastolic BP (mmHg)	75.2 ± 7.6	72.6 ± 8.7	81.8 ± 9.0	<0.01	<0.01
FBG (mmol/l)	7.18 ± 1.69	6.41 ± 1.91	4.98 ± 0.33	<0.01	<0.01
A1c (%)	6.4 ± 2.4	7.4 ± 1.2	5.5 ± 0.6	0.07	<0.01
total cholesterol (mmol/l)	4.44 ± 0.87	4.56 ± 0.97	4.94 ± 1.04	<0.05	NS
HDL-cholesterol (mmol/l)	1.23 ± 0.35	1.18 ± 0.28	1.43 ± 0.43	<0.05	0.07
LDL-cholesterol (mmol/l)	2.35 ± 0.64	2.64 ± 0.86	2.96 ± 0.84	<0.01	NS
triglycerides (mmol/l)	1.45 (1.07–2.07)	1.36 (1.05–1.84)	1.14 (0.78–1.48)	<0.05	NS
HOMA-%B1	77.1 ± 42.7	80.5 ± 46.1	107.8 ± 40.0	<0.01	NS
HOMA-IR1	2.12 ± 1.28	2.43 ± 1.39	1.27 ± 0.64	<0.05	NS
fasting C-peptide (nmol/l)	0.78 ± 0.50	0.77 ± 0.56	0.57 ± 0.29	NS	NS
				p2
females (%)	68.8	72.2	83.3	NS
hypertension (%)	85.4	72.2	50	<0.01
obesity (%)	31.3	22.2	11.9	NS
overweight (%)	83.3	66.7	52.4	<0.01
central obesity (%)	62.5	61.1	38.1	0.051
low HDL (%)	63.8	50	34.1	<0.05
hypertriglyceridemia (%)	38.8	33.3	17.7	NS
dyslipidemia treatment (%)3	8.3	0	7.1	NS
metabolic syndrome (%)	87.5	77.8	11.9	<0.01
insulin treatment (%)4	14.9	37.5	-	0.054
positive GADA (%)	4.9	0	2.6	NS

¹calculated in 39 individuals from group CT2DM, 14 from LOADDM, and 39 from N; ²Two df significance, except ⁴(one df); ³current or previous use of fibrates/statins; NS denotes p< 0.10